Literature DB >> 24352130

Correlates of non-adherence to antiretroviral therapy in a cohort of HIV-positive drug users receiving antiretroviral therapy in Hanoi, Vietnam.

M R Jordan1,2, Y Obeng-Aduasare1, H Sheehan1, S Y Hong1,2, N Terrin2, D V Duong3, N V Trung3, C Wanke1,2, N V Kinh3, A M Tang1.   

Abstract

The HIV epidemic in Vietnam is concentrated, with high prevalence estimates among injection drug users and commercial sex workers. Socio-demographics, substance use and clinical correlates of antiretroviral therapy non-adherence were studied in 100 HIV-1 infected drug users receiving antiretroviral therapy for at least 6 months in Hanoi, Vietnam. All study participants were men with a mean age of 29.9 ± 4.9 years. The median duration on antiretroviral therapy was 16.2 ± 12.7 months; 83% reported 'very good' or 'perfect' adherence in the past 30 days on a subjective one-item Likert scale at time of study enrollment; 48% of participants reported drug use within the previous 6 months, with 22% reporting current drug use. Injection drug use with or without non-injection drug use in the past 6 months (95% C.I. 2.19, 1.30-3.69) and years on antiretroviral therapy (95% C.I. 1.43, 1.14-1.78) were correlated with suboptimal adherence. These findings support Vietnam's ongoing scale-up of harm reduction programmes for injection drug users and their integration with antiretroviral therapy delivery. Moreover, results highlight the need to identify and implement new ways to support high levels of antiretroviral therapy adherence as duration on antiretroviral therapy increases.
© The Author(s) 2013 Reprints and permissions: sagepub.co.uk/journalsPermissions.nav.

Entities:  

Keywords:  AIDS; HIV; Vietnam; adherence; antiretroviral therapy; injection drug users; substance abuse

Mesh:

Substances:

Year:  2013        PMID: 24352130      PMCID: PMC4062600          DOI: 10.1177/0956462413516301

Source DB:  PubMed          Journal:  Int J STD AIDS        ISSN: 0956-4624            Impact factor:   1.359


  27 in total

1.  Impact of active drug use on antiretroviral therapy adherence and viral suppression in HIV-infected drug users.

Authors:  Julia H Arnsten; Penelope A Demas; Richard W Grant; Marc N Gourevitch; Homayoon Farzadegan; Andrea A Howard; Ellie E Schoenbaum
Journal:  J Gen Intern Med       Date:  2002-05       Impact factor: 5.128

2.  Optimal recall period and response task for self-reported HIV medication adherence.

Authors:  Minyi Lu; Steven A Safren; Paul R Skolnik; William H Rogers; William Coady; Helene Hardy; Ira B Wilson
Journal:  AIDS Behav       Date:  2007-06-19

Review 3.  Adherence-resistance relationships to combination HIV antiretroviral therapy.

Authors:  David R Bangsberg; Deanna L Kroetz; Steven G Deeks
Journal:  Curr HIV/AIDS Rep       Date:  2007-05       Impact factor: 5.071

4.  Determinants of optimal adherence over time to antiretroviral therapy amongst HIV positive adults in South Africa: a longitudinal study.

Authors:  Dikokole Maqutu; Temesgen Zewotir; Delia North; Kogieleum Naidoo; Anneke Grobler
Journal:  AIDS Behav       Date:  2011-10

5.  Pharmacy adherence measures to assess adherence to antiretroviral therapy: review of the literature and implications for treatment monitoring.

Authors:  James H McMahon; Michael R Jordan; Karen Kelley; Silvia Bertagnolio; Steven Y Hong; Christine A Wanke; Sharon R Lewin; Julian H Elliott
Journal:  Clin Infect Dis       Date:  2011-01-18       Impact factor: 9.079

6.  Changes in drug use are associated with health-related quality of life improvements among methadone maintenance patients with HIV/AIDS.

Authors:  Bach Xuan Tran; Arto Ohinmaa; Anh Thuy Duong; Nhan Thi Do; Long Thanh Nguyen; Quoc Cuong Nguyen; Steve Mills; Philip Jacobs; Stan Houston
Journal:  Qual Life Res       Date:  2011-07-06       Impact factor: 4.147

7.  Factors associated with virological suppression among HIV-positive individuals on highly active antiretroviral therapy in a multi-site Canadian cohort.

Authors:  A M Cescon; C Cooper; K Chan; A K Palmer; M B Klein; N Machouf; M R Loutfy; J Raboud; A Rachlis; E Ding; V D Lima; J S G Montaner; S B Rourke; M Smieja; C Tsoukas; R S Hogg
Journal:  HIV Med       Date:  2010-11-08       Impact factor: 3.180

8.  Epidemiology of HIV among injecting and non-injecting drug users: current trends and implications for interventions.

Authors:  Steffanie A Strathdee; Jamila K Stockman
Journal:  Curr HIV/AIDS Rep       Date:  2010-05       Impact factor: 5.071

9.  Factors associated with non-adherence to highly active antiretroviral therapy in Nairobi, Kenya.

Authors:  Samwel N Wakibi; Zipporah W Ng'ang'a; Gabriel G Mbugua
Journal:  AIDS Res Ther       Date:  2011-12-05       Impact factor: 2.250

10.  Multilevel predictors of concurrent opioid use during methadone maintenance treatment among drug users with HIV/AIDS.

Authors:  Bach Xuan Tran; Arto Ohinmaa; Steve Mills; Anh Thuy Duong; Long Thanh Nguyen; Philip Jacobs; Stan Houston
Journal:  PLoS One       Date:  2012-12-12       Impact factor: 3.240

View more
  6 in total

1.  Pretreatment HIV-1 drug resistance to first-line drugs: results from a baseline assessment of a large cohort initiating ART in Vietnam, 2009-10.

Authors:  Quang Duy Pham; Nhan Thi Do; Yen Ngoc Le; Thuong Vu Nguyen; Duc Bui Nguyen; Thu Khanh Hoang Huynh; Duong Duc Bui; Nghia Van Khuu; Phuc Duy Nguyen; Anh Que Luong; Hien Thu Bui; Hai Huu Nguyen; Michelle McConnell; Long Thanh Nguyen; Lei Zhang; Lien Xuan Truong
Journal:  J Antimicrob Chemother       Date:  2014-11-27       Impact factor: 5.790

2.  Long-term viral suppression and immune recovery during first-line antiretroviral therapy: a study of an HIV-infected adult cohort in Hanoi, Vietnam.

Authors:  Junko Tanuma; Shoko Matsumoto; Sebastien Haneuse; Do Duy Cuong; Tuong Van Vu; Pham Thi Thanh Thuy; Nguyen Thi Dung; Nguyen Thi Hoai Dung; Nguyen Vu Trung; Nguyen Van Kinh; Shinichi Oka
Journal:  J Int AIDS Soc       Date:  2017-12       Impact factor: 5.396

Review 3.  Challenges in managing HIV in people who use drugs.

Authors:  Adeeba Kamarulzaman; Frederick L Altice
Journal:  Curr Opin Infect Dis       Date:  2015-02       Impact factor: 4.915

4.  HIV Patients' Preference for Integrated Models of Addiction and HIV Treatment in Vietnam.

Authors:  Diep Nguyen Bich; P Todd Korthuis; Trang Nguyen Thu; Hoa Van Dinh; Giang Le Minh
Journal:  J Subst Abuse Treat       Date:  2016-07-19

5.  Prevalence and determinants of virological failure, genetic diversity and drug resistance among people living with HIV in a minority area in China: a population-based study.

Authors:  Dan Yuan; Meijing Liu; Peng Jia; Yiping Li; Yuling Huang; Li Ye; Laze Api; Maogang Chen; Liang Yao; Zixin Wang; Honglu Liu; Shu Liang; Shujuan Yang
Journal:  BMC Infect Dis       Date:  2020-06-23       Impact factor: 3.090

6.  Perceived need, barriers to and facilitators of mental health care among HIV-infected PWID in Hanoi, Vietnam: a qualitative study.

Authors:  Minh X Nguyen; Vivian F Go; Quynh X Bui; Bradley N Gaynes; Brian W Pence
Journal:  Harm Reduct J       Date:  2019-12-26
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.